CANbridge Life Sciences
2012
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series B
LATEST DEAL TYPE
$21M
LATEST DEAL AMOUNT
8
INVESTORS
Description
Developer of specialty healthcare products designed to treat critical medical conditions. The company's specialty healthcare products prevent and treat oral mucositis, enabling patients to access improved treatment.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
- Suite 301, 3F, Timeloit
- Number 17 RongChuang Road
- Beijing, Chaoyang 100102
- China
+86 010 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore CANbridge Life Sciences’s full profile, request a free trial.
CANbridge Life Sciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 21-Feb-2017 | $21M | 0000 | 0000 | Completed | Startup |
| 3. Early Stage VC (Series A2) | 01-Nov-2015 | 000 | 0000 | 0000 | Completed | Startup |
| 2. Early Stage VC (Series A1) | 01-Dec-2014 | $5M | $10M | 0000 | Completed | Startup |
| 1. Angel (individual) | $5M | $5M | Completed | Startup |
CANbridge Life Sciences Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| AppTec Laboratory Services | Corporation | Minority | 000 0000 | 000000 0 | ||
| Biossom Investment Management | Other | Minority | 000 0000 | 000000 0 | ||
| Lapam Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Yanyuan Capital | Other | Minority | 000 0000 | 000000 0 | ||
| YuanMing Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
CANbridge Life Sciences Executive Team (9)
1 Former Executive
You’re viewing 5 of 9 executives. Get the full list »CANbridge Life Sciences Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| James Xue Ph.D | CANbridge Life Sciences | Founder, Chief Executive Officer and Chairman | 000 0000 | |
| William Hu | Qiming Venture Partners | Board Member | 000 0000 |